SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $453,000 | +387.1% | 150,400 | +295.2% | 0.00% | – |
| Q1 2015 | $93,000 | -64.6% | 38,056 | -63.1% | 0.00% | -100.0% |
| Q4 2014 | $263,000 | -61.4% | 103,112 | +8.0% | 0.00% | -66.7% |
| Q3 2014 | $682,000 | +176.1% | 95,462 | +152.2% | 0.00% | +200.0% |
| Q2 2014 | $247,000 | +41.1% | 37,850 | +42.8% | 0.00% | 0.0% |
| Q1 2014 | $175,000 | +48.3% | 26,500 | +6.4% | 0.00% | – |
| Q4 2013 | $118,000 | -7.1% | 24,899 | -3.0% | 0.00% | -100.0% |
| Q3 2013 | $127,000 | +4.1% | 25,659 | +10.0% | 0.00% | 0.0% |
| Q2 2013 | $122,000 | – | 23,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |